1   Qin X, Ma D, Tan Y^#, Wang H^#, Cai Z^#. The role of necroptosis in cancer: a double-edged sword? 2019, Biochim Biophys Acta Rev Cancer, 1871:259-266. (^#, Correspondence author) (Review) IF:8.220

        2     Chen X^†, Zhuang C^†,#, Ren Y^†, Zhang H, Qin X, Hu L, Fu J, Miao Z, Chai Y, Liu Z, Cai Z^#, Wang H^# , Identification of TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3, 2019, Br J Pharmacol, 176(12):2095-2108, (#, Correspondence author; †, equal contribution)  IF: 6.810

        3     Zhang H^†, Xu L^†, Qin X^†, Chen X, Cong H, Hu L, Miao Z, Zhang W^#, Cai Z^#, Zhuang C^#. TAK-632 Analogues as Novel Necroptosis Inhibitors Selectively Targeting RIPK3: Synthesis, Structure-Activity Relationships and In Vivo Efficacy, 2019, J Med Chem, 62(14):6665-6681， (#, Correspondence author; †, equal contribution)  (Cover Story) IF: 6.253

        4     Pan P, Cai Z, Zhuang C, Chen X, Chai Y. Methodology of drug screening and target identification for new  necroptosis inhibitors, 2019, J Pharm Anal, 9(2):71-76. (Review)